The New Treatment in Amblyopia Therapy Clinical Trial
Official title:
Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences
The purpose of this study is to investigate the effect of amblyopia therapy on cases who will
receive Interactive Binocular Treatment (IBiTTM) without patching compared with those who
will receive standard patching of the dominant eye with placebo IBiTTM.
In this randomized clinical trial, 40 unilateral amblyopic children (3 to 10 years old) will
be studied. All unilateral functional amblyopic children with best corrected visual acuity
(BCVA) worse than 0.30 LogMAR at least in one eye or a difference of two BCVA lines of
Snellen between the two eyes will be included and randomly will divide into the case (n=19)
and control (n=21) groups. Cases will play I-BiT™ games, while controls will have standard
patch therapy and will play with placebo IBiTTM for one month. All subjects will be underwent
comprehensive ophthalmic examinations at baseline and at one-month follow-up.
n/a